How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance

Abstract

Cancer is the second leading cause of death worldwide. The survival of cancer patients depends on the efficacy of therapies and the development of resistance. There are many mechanisms involved in the acquisition of drug resistance by cancer cells, including the acquisition of stem-like features. Cancer stem cells (CSCs) represent a major source of tumor progression and treatment resistance. CSCs are a subpopulation of cancer cells having the abilities to self-renew and form spheres in vitro. Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cytosolic enzyme involved in the detoxification of cells from toxic aldehydes and belongs to the ALDH family. High ALDH1A1 activity is closely related to stemness phenotype of several tumors, possibly contributing to cancer progression and diffusion in the body. We have documented the contribution of ALDH1A1 in tumor angiogenesis in breast cancer cells by the activation of hypoxia inducible factor-1α and vascular endothelial growth factor signaling. This review discusses the involvement of ALDH1A1 in the development of different hallmarks of cancer to propose it as a novel putative target for cancer treatment to achieve better outcome. Here, we analyze the involvement of ALDH1A1 in the acquisition of stemness phenotype in tumor cells, the regulation of tumor angiogenesis and metastases, and the acquisition of anticancer drug resistance and immune evasion.

Keywords

Aldehyde dehydrogenase 1A1 / angiogenesis / drug resistance / immune editing / metastases / stemness

References

[1] Hanahan D.The hallmarks of cancer..Cell2000;100:57-70

[2] Hanahan D.Hallmarks of cancer: the next generation..Cell2011;144:646-74

[3] Horne SD,Heng HH.Evolutionary mechanism unifies the hallmarks of cancer..Int J Cancer2015;136:2012-21

[4] Saygin C,Majeti R,Lathia JD.Targeting cancer stemness in the clinic: from hype to hope..Cell Stem Cell2019;24:25-40

[5] Schulenburg A,Cerny-Reiterer S,Herrmann H.Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?.J Hematol Oncol2015;8:16 PMCID:PMC4345016

[6] Skvortsova I,Kumar V.Radiation resistance: cancer stem cells (CSCs) and their enigmatic pro-survival signaling..Semin Cancer Biol2015;35:39-44

[7] Iscove NN.Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion..Curr Biol1997;7:805-8

[8] Yin H,Porter NA.Free radical lipid peroxidation: mechanisms and analysis..Chem Rev2011;111:5944-72

[9] Grune T.Protein oxidation products as biomarkers..Free Radic Biol Med.2014;75 Suppl 1:S7

[10] O’Brien PJ,Shangari N.Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health..Crit Rev Toxicol2005;35:609-62

[11] Vassalli G.Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells..Stem Cells Int2019;2019:3904645 PMCID:PMC6348814

[12] Dockham PA,Sladek NE.Relative contribution of human erythrocyte aldehyde dehydrogenase to the systemic detoxification of the oxazaphosphorines..Drug Metab Dispos1997;25:1436-41

[13] Allison SE,Petrovic N,Bourget K.Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species..Biochem Pharmacol2017;143:79-89

[14] Yoshida A,Han H.Enhanced transcription of the cytosolic ALDH gene in cyclophosphamide resistant human carcinoma cells..Adv Exp Med Biol1993;328:63-72

[15] Notas G,Kampa M,Sfakianakis S.Tamoxifen induces a pluripotency signature in breast cancer cells and human tumors..Mol Oncol2015;9:1744-59 PMCID:PMC5528714

[16] Khoury T,Chandrasekhar R,Deleo A.Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy..Mod Pathol2012;25:388-97 PMCID:PMC3426278

[17] Chen DS.Elements of cancer immunity and the cancer-immune set point..Nature.2017;541:321-30

[18] Tomasetti C.Variation in cancer risk among tissues can be explained by the number of stem cell divisions..Science2015;347:78-81 PMCID:PMC4446723

[19] Valent P,De Maria R,Copland M.Cancer stem cell definitions and terminology: the devil is in the details..Nat Rev Cancer2012;12:767-75

[20] Batlle E.Cancer stem cells revisited..Nat Med2017;23:1124-34

[21] Phi LTH,Yang YG,Jun N.Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment..Stem Cells Int2018;2018:5416923 PMCID:PMC5850899

[22] Chen W,Haiech J,Zeniou M.Cancer stem cell quiescence and plasticity as major challenges in cancer therapy..Stem Cells Int2016;2016:1740936 PMCID:PMC4932171

[23] Annett S.Targeting cancer stem cells in the clinic: current status and perspectives..PharmacolTher2018;187:13-30

[24] Zhao W,Zhang X.Stemness-related markers in cancer..Cancer Transl Med2017;3:87-95 PMCID:PMC5737740

[25] Huang EH,Zhang T,Dontu G.Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis..Cancer Res2009;69:3382-9 PMCID:PMC2789401

[26] Ginestier C,Charafe-Jauffret E,Dutcher J.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome..Cell Stem Cell2007;1:555-67 PMCID:PMC2423808

[27] Jiang F,Khanna A,Deepak J.Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer..Mol Cancer Res2009;7:330-8 PMCID:PMC4255559

[28] Li T,Mei Y,Leng B.ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome..Lab Invest2010;90:234-44 PMCID:PMC3552330

[29] Li Y,Yang Z,Quan X.Bladder cancer stem cells: clonal origin and therapeutic perspectives..Oncotarget2017;8:66668-79 PMCID:PMC5630446

[30] Landen CN,Katre AA,Nick AM.Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer..Mol Cancer Ther2010;9:3186-99 PMCID:PMC3005138

[31] Moreb JS.Aldehyde dehydrogenase as a marker for stem cells..Curr Stem Cell Res Ther2008;3:237-46

[32] Sullivan JP,Dodge M,Behrens C.Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling..Cancer Res2010;70:9937-48 PMCID:PMC3058307

[33] Minato T,Seike J,Yamai H.Aldehyde dehydrogenase 1 expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma..Ann Surg Oncol2013;20:209-17

[34] Li X,Fu X.ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer..BMC Cancer2014;14:705 PMCID:PMC4180139

[35] Somasagara RR,Tripathi K,Mani C.RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance..Oncogene2017;36:6680-90 PMCID:PMC5709226

[36] Xu SL,Dong WG,Rao J.Distinct patterns of ALDH1A1 expression predict metastases and poor outcome of colorectal carcinoma..Int J Clin Exp Pathol2014;7:2976-86 PMCID:PMC4097282

[37] Seitz HK.Molecular mechanisms of alcohol-mediated carcinogenesis..Nat Rev Cancer2007;7:599-612

[38] Niederreither K,Dollé P.Embryonic retinoic acid synthesis is essential for early mouse post-implantation development..Nature Genetics1999;21:444-8

[39] Marcato P,Liu RZ,Bydoun M.Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling..Mol Oncol2015;9:17-31 PMCID:PMC5528683

[40] Luo Y,Chen Y,Robinson SE.ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets..Stem Cells2012;30:2100-13 PMCID:PMC3448863

[41] Xu X,Wang P,Yang Y.Aldehyde dehydrogenases and cancer stem cells..Cancer Lett2015;369:50-7

[42] Marchitti SA,Stagos D.Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily..Expert Opin Drug MetabToxicol2008;4:697-720 PMCID:PMC2658643

[43] Celià-Terrassa T.Metastatic niche functions and therapeutic opportunities..Nat Cell Biol2018;20:868

[44] Aponte PM.Stemness in cancer: stem cells, cancer stem cells, and their microenvironment..Stem Cells Int2017;2017:5619472 PMCID:PMC5394399

[45] Plaks V,Werb Z.The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?.Cell Stem Cell2015;16:225-38 PMCID:PMC4355577

[46] Visvader JE.Tissue-specific designs of stem cell hierarchies..Nat Cell Biol2016;18:349-55

[47] Menendez JA.Metabostemness: a new cancer hallmark..Front Oncol2014;4:262 PMCID:PMC4179679

[48] Reya T,Clarke MF.Stem cells, cancer, and cancer stem cells..Nature2001;414:105-11

[49] Beck B.Unravelling cancer stem cell potential..Nat Rev Cancer2013;13:727-38

[50] La Porta CAM.Complexity in cancer stem cells and tumor evolution: toward precision medicine..Semin Cancer Biol2017;44:3-9

[51] Tomita H,Tanaka T.Aldehyde dehydrogenase 1A1 in stem cells and cancer..Oncotarget2016;7:11018-32 PMCID:PMC4905455

[52] Johnson S,Lo PK.In vitro tumorsphere formation assays..Bio Protoc2013;3:e325 PMCID:PMC4972326

[53] Friedl P.Cancer invasion and the microenvironment: plasticity and reciprocity..Cell2011;147:992-1009

[54] Lu P,Weaver VM.Extracellular matrix degradation and remodeling in development and disease..Cold Spring Harb Perspect Biol2011;3:a005058 PMCID:PMC3225943

[55] Chen Y,Matsumoto A,Thompson DC.Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer..Biochem Biophys Res Commun2011;405:173-9 PMCID:PMC3112362

[56] Marchitti SA,Brocker C.Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues..J Histochem Cytochem2010;58:765-83 PMCID:PMC2924794

[57] Patel M,Zander DS,Coco D.ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors..Lung Cancer2008;59:340-9

[58] Leid M,Chambon P.Multiplicity generates diversity in the retinoic acid signalling pathways..Trends Biochem Sci1992;17:427-33

[59] Yang L,Yu X,Bian BS.ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma..Modern Pathology2014;27:775-83

[60] Xu SL,Cui W,Liu Q.Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis..Am J Cancer Res2015;5:1471-83 PMCID:PMC4473324

[61] Croker AK,Xia Y,Leong HS.Differential functional roles of ALDH1A1 and ALDH1A3 in mediating metastatic behavior and therapy resistance of human breast cancer cells..Int J Mol Sci2017;18:E2039 PMCID:PMC5666721

[62] Liu Y,Duan J,Zhang JF.ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis..BMC Cancer2014;14:444 PMCID:PMC4070403

[63] Kahlert C,Beck J,Mogler C.Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer..BMC Cancer2011;11:275 PMCID:PMC3135572

[64] Rasheed ZA,Wang Q,Freed I.Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma..J Natl Cancer Inst2010;102:340-51 PMCID:PMC2831049

[65] Prasmickaite L,Skrbo N,Kristian A.Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma..PLoS One2010;5:e10731 PMCID:PMC2874003

[66] Boonyaratanakornkit JB,Strachan LR,LeBoit PE.Selection of tumorigenic melanoma cells using ALDH..J Invest Dermatol2010;130:2799-808 PMCID:PMC5621840

[67] Ping YF,Bian XW.Cancer stem cells and their vascular niche: do they benefit from each other?.Cancer Lett2016;380:561-7

[68] Hanahan D.Accessories to the crime: functions of cells recruited to the tumor microenvironment..Cancer Cell2012;21:309-22

[69] Salmaggi A,Gelati M,Calatozzolo C.Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype..Glia2006;54:850-60

[70] Balic M,Young L,Giuliano A.Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype..Clin Cancer Res2006;12:5615-21

[71] Bickel ST,Nagy JD.Evolution of proliferation and the angiogenic switch in tumors with high clonal diversity..PLoS One2014;9:e91992 PMCID:PMC3986075

[72] Bao S,Sathornsumetee S,Li Z.Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor..Cancer Res2006;66:7843-8

[73] Ciccone V,Donnini S,Morbidelli L.Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells..J Exp Clin Cancer Res2018;37:311 PMCID:PMC6291966

[74] Ciccone V,Donnini S,Morbidelli L.Correction to: stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells..J Exp Clin Cancer Res2019;38:45 PMCID:PMC6357458

[75] Lv X,Song Y,Li H.Association between ALDH1+/CD133+ stem-like cells and tumor angiogenesis in invasive ductal breast carcinoma..Oncol Lett2016;11:1750-6 PMCID:PMC4774434

[76] Silva IA,McLean K,Griffith K.Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival..Cancer Res2011;71:3991-4001 PMCID:PMC3107359

[77] Ohmura-Kakutani H,Maishi N,Hida Y.Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype..PLoS One2014;9:e113910 PMCID:PMC4250080

[78] White HS,Gentry T.Mechanisms of action of human aldehyde dehydrogenase bright cells in therapy of cardiovascular diseases: expression analysis of angiogenic factors and aldehyde dehydrogenase isozymes..J Stem Cell Res Ther2011;

[79] Li X,Geng J,Bai X.Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome..J Thorac Oncol2012;7:1235-45

[80] Wang K,Zhan Y,Liu X.Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma..Med Oncol2013;30:574

[81] Van den Hoogen C,Cheung H,Lippitt JM.High aldehyde dehydrogenase activity identifies tumor-initiating and metastases-initiating cells in human prostate cancer..Cancer Res2010;70:5163-73

[82] Kalantari E,Asgari M,Roudi R.Increased expression of ALDH1A1 in prostate cancer is correlated with tumor aggressiveness: a tissue microarray study of iranian patients..Appl Immunohistochem Mol Morphol2017;25:592-8

[83] Yao J,Wang XD,Ni QC.Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer..Medicine (Baltimore)2017;96:e7171 PMCID:PMC5484203

[84] van der Waals LM,Kranenburg O.ALDH1A1 expression is associated with poor differentiation, ‘right-sidedness’ and poor survival in human colorectal cancer..PLoS One2018;13:e0205536 PMCID:PMC6181398

[85] Liao J,Tchabo N,Beck A.Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastases and chemotherapy resistance through hypoxia-resistant metabolism..PLoS One2014;9:e84941 PMCID:PMC3883678

[86] Sun L,Guo C,Yang Z.Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma..Dis Esophagus2017;30:1-5

[87] Yue L,Fong S,Jakowatz JG.Targeting ALDH1 to decrease tumorigenicity, growth and metastases of human melanoma..Melanoma Res2015;25:138-48

[88] Hilton J.Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia..Cancer Res1984;44:5156-60

[89] Sreerama L.Cellular levels of class 1 and class 3 aldehyde dehydrogenases and certain other drug-metabolizing enzymes in human breast malignancies..Clin Cancer Res1997;3:1901-14

[90] Yao S,Zhao H,Zirpoli G.Germline genetic variants in ABCB1, ABCC1, and ALDH1A1 and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer..Pharmacogenomics J2014;14:241-7 PMCID:PMC3940691

[91] Duong HQ,Kim HJ,Seong YS.Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells..Int J Oncol2012;41:855-61 PMCID:PMC3508685

[92] Kulsum S,Pandian R,Siddappa G.Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition..Mol Carcinog2017;56:694-711

[93] Lei HM,Wang CH,Zhuang GL.Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas..Theranostics2019;9:7122-39 PMCID:PMC6831290

[94] Voronkova MA,Kiratipaiboon C.SOX9-ALDH axis determines resistance to chemotherapy in non-small cell lung cancer..Mol Cell Biol2019;

[95] Wei Y,Xu W,Li Y.Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP..Thorac Cancer2017;8:26-32 PMCID:PMC5217899

[96] Kaipio K,Roering P,Mikkonen P.ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors..J Pathol2019;

[97] Świerczewska M,Wojtowicz K,Iżycki D.PTPRK expression is downregulated in drug resistant ovarian cancer cell lines, and especially in ALDH1A1 positive CSCs-like populations..Int J Mol Sci2019;20:2053 PMCID:PMC6515253

[98] Mori Y,Ishiguro T,Ueda H.ALDH-dependent glycolytic activation mediates stemness and paclitaxel resistance in patient-derived spheroid models of uterine endometrial cancer..Stem Cell Reports2019;13:730-46 PMCID:PMC6829754

[99] Cojoc M,Kurth I,Kunz-Schughart LA.Aldehyde Dehydrogenase is regulated by β-catenin/TCF and promotes radioresistance in prostate cancer progenitor cells..Cancer Res2015;75:1482-94

[100] Mitsuhashi A,Saijo A,Aono Y.Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab..Nat Commun2015;6:8792 PMCID:PMC4686833

[101] Yang H,Zhou Y,Zeng T.Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma..Oncotarget2015;6:26079-89 PMCID:PMC4694887

[102] Najafi M,Majidpoor J.Cancer stem cell (CSC) resistance drivers..Life Sci2019;234:116781

[103] Schatton T.Antitumor immunity and cancer stem cells..Ann N Y Acad Sci2009;1176:154-69 PMCID:PMC2893543

[104] Maccalli C,Ferrone S.Cancer stem cell resistance to targeted therapy.2019;Springer International Publishing

[105] Irvin DK,Duvall G,Yuying Z.T cells enhance stem-like properties and conditional malignancy in gliomas..PLoS One2010;5:e10974 PMCID:PMC2881867

[106] Hsu JM,Hsu YH,Yu WH.STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion..Nat Commun2018;9:1908 PMCID:PMC5954021

[107] Castagnoli L,Cordoba-Romero SL,Talarico G.WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer..Oncogene2019;38:4047-60 PMCID:PMC6755989

[108] Sultan M,Paine AS,Coyle KM.Epigenetic silencing of TAP1 in Aldefluor+ breast cancer stem cells contributes to their enhanced immune evasion..Stem Cells2018;36:641-54

[109] Desai A,Gerson SL.Concise reviews: cancer stem cell targeted therapies: toward clinical success..Stem Cells Transl Med2019;8:75-81 PMCID:PMC6312440